US Neurosurgical

US Neurosurgical most commonly refers to the legacy U.S. NeuroSurgical business and public company that operated Gamma Knife radiosurgery centers and related healthcare ventures. The public entity historically known as U.S. NeuroSurgical Holdings later changed its corporate name to Elite Health Systems in September 2024 and is now developing a Medicare Advantage health plan business, initially focused on California and Nevada. Historically, the company has been associated with medical diagnosis and treatment services, including neurosurgical and radiation-treatment-center activities, as well as other healthcare service initiatives. It is not a biotechnology or drug-development company and does not appear to have a therapeutic drug pipeline. The entity remains active as a public healthcare services company rather than a pharma or biotech developer.